A new international study led by Nanyang Technological University Singapore aims to uncover insights about Asian medical professionals’ perceptions of the use of AI in healthcare.
DETECT
Researchers surveyed 165 gastroenterologists and digestive surgeons from Singapore, China, Hong Kong, and Taiwan. They were administered a questionnaire asking to rate their level of agreement with statements to assess their trust, acceptance, and risk perception of the use of AI in gastroenterology. The questionnaire presents three different scenarios in which AI is possible application – detection, characterization and intervention.
Based According to results published in the scientific journal JMIR (Journal of Medical Internet Research) AI, about 8/10 respondents said they accept and trust the use of AI in diagnosis and assessment. colorectal polyps. About 70% said they accept and trust AI-enabled tools in polyp removal, while about 80% said they accept and trust AI in identifying polyp characteristics.
The researchers noted that although there were no differences in adoption levels between public and private practices as well as large hospitals and small practice groups, years of experience may be an indicator about trust in AI. The survey found that gastroenterologists with less than a decade of clinical experience perceived more risks when using AI-powered tools than more experienced physicians.
“More clinical experience in the management of colorectal polyps among senior gastroenterologists may help clinicians,” said Joseph Sung, an NTU professor and one of the researchers. These individuals are more confident in their medical expertise and practice, which in turn creates greater confidence in making clinical decisions as new technologies are introduced.” co-author of the study, explains.
Professor Sung also said that young gastroenterologists may find AI risky because they lack confidence in using it for invasive procedures, such as polyp removal.
BIGGER TREND
Wilson Goh, an assistant professor at the NTU Lee Kong Chian School of Medicine who led the study, said they focused on gastroenterologists due to their “high use of imaging-based diagnosis and surgical intervention.” or endoscopy”.
This is evident in the growing availability of AI-powered tools, software and decision support systems for diagnosing and treating digestive disorders across Asia.
Japanese companies, AI Medical Service (AIM) and NEC are well-known diagnostic endoscopy AI developers. AIM is currently collaborating with Stanford University School of Medicine to verify its products. Chinese startups Wision AI also offers CE-marked AI-powered polyp detection software called EndoScreener.
Meanwhile, Asian universities and hospitals, incl The Chinese University of Hong Kong, Thailand’s Chulalongkorn University and the National University Hospital in Singapore have built an AI-driven endoscopy system to assist in detecting, diagnosing and removing tract cancer lesions. Digest.
